STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Recursion Pharmaceuticals (RXRX) insider files to sell 50,000 Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Christopher C. Gibson filed a notice to sell up to 50,000 Class A shares of RXRX through Fidelity Brokerage Services LLC, with an estimated aggregate market value of $168,500.00 on NASDAQ. The shares are described as Founders Shares originally acquired from the issuer on 04/20/2021 as compensation.

The filing also lists extensive Class A share sales during the prior three months by Christopher C. Gibson and related entities, including Gibson Family Trust and Lahwran-3 LLC, covering multiple transactions between 05/22/2026 and 08/10/2026, with individual trades ranging from 40,000 to 340,440 shares and transaction values up to about $1.09 million.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 50,000 shares Planned Class A sale via Fidelity Brokerage Services LLC
Aggregate market value of proposed sale $168,500.00 Estimated value of 50,000 Class A shares on NASDAQ
Largest single recent sale by Christopher C. Gibson 340,440 shares for $1,089,541.29 Class A sale dated 06/18/2026
Lahwran-3 LLC notable sale 186,000 shares for $706,094.96 Class A sale dated 07/09/2026
Founders shares acquired date 04/20/2021 Original acquisition of founders shares from issuer as compensation
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Founders Shares | Issuer | | | 50000"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
aggregate market value financial
"50000 | 168500.00 | 535342170 | 08/12/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Compensation financial
"50000 | 04/20/2021 | Compensation"
Class A financial
"Class A | Fidelity Brokerage Services LLC"
Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What is included in the RXRX Form 144 filed by Christopher C. Gibson?
The Form 144 lists a proposed sale of 50,000 Class A shares of RXRX with an estimated value of $168,500.00, plus detailed records of multiple Class A share sales in the prior three months.

How many RXRX shares does Christopher C. Gibson plan to sell under this Form 144?
Christopher C. Gibson plans to sell up to 50,000 Class A shares of RXRX. The filing shows these as Founders Shares held at Fidelity Brokerage Services LLC, with an aggregate market value estimate of $168,500.00 on NASDAQ.

What past RXRX share sales are disclosed for Christopher C. Gibson in this Form 144?
The filing lists multiple RXRX Class A sales from 05/22/2026 to 08/10/2026, including trades of 40,000 to 340,440 shares, with individual transaction values up to about $1,089,541.29 for the largest single sale.

On which market are the RXRX shares in this Form 144 traded?
The RXRX Class A shares referenced in the Form 144 are associated with trading on NASDAQ. The proposed 50,000-share sale through Fidelity Brokerage Services LLC uses an aggregate market value estimate based on that listing.

When were the RXRX founders shares originally acquired that are now planned for sale?
The founders shares of RXRX now planned for sale were originally acquired on 04/20/2021 from the issuer as compensation. The current Form 144 covers up to 50,000 of these Class A shares.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR